ATRIDOX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Atridox, and when can generic versions of Atridox launch?
Atridox is a drug marketed by Den-mat and is included in one NDA.
The generic ingredient in ATRIDOX is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Atridox
A generic version of ATRIDOX was approved as doxycycline hyclate by CARIBE HOLDINGS on November 8th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ATRIDOX?
- What are the global sales for ATRIDOX?
- What is Average Wholesale Price for ATRIDOX?
Summary for ATRIDOX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 55 |
Clinical Trials: | 2 |
Patent Applications: | 438 |
What excipients (inactive ingredients) are in ATRIDOX? | ATRIDOX excipients list |
DailyMed Link: | ATRIDOX at DailyMed |
Recent Clinical Trials for ATRIDOX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The Forsyth Institute | Phase 2 |
National Institute of Dental and Craniofacial Research (NIDCR) | Phase 2 |
Milton S. Hershey Medical Center | N/A |
US Patents and Regulatory Information for ATRIDOX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Den-mat | ATRIDOX | doxycycline hyclate | SYSTEM, EXTENDED RELEASE;PERIODONTAL | 050751-001 | Sep 3, 1998 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |